Kleresca Approved in EU for Dermatological Platform

Dermatological device developer Kleresca gained a CE Mark for its biophotonic dermatological system.

The device uses a non-invasive fluorescent light treatment to encourage the skin’s biological processes, repair skin in patients and treat rosacea. It can also be used as an add-on treatment for other dermatological procedures, such as laser treatments.

The device cannot cause a photosensitive reaction because the treatment gel is not absorbed by the skin, and the treatment does not damage the skin’s natural barriers.